Israel’s Rosetta Genomics Ltd. Ups IPO Shares, Lowers Price

January 24, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, Jan 23 (Reuters) - Israel's Rosetta Genomics Ltd., a diagnostic and therapeutic products maker, on Tuesday increased the number of shares planned for its initial public offering to 3.75 million from 3 million.

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

IPO